<PAGE>

                                                                   EXHIBIT 10.25

                            STOCK OPTION CERTIFICATE

      This Stock Option Certificate is entered into between STAAR Surgical
Company, a Delaware corporation (the "Company"), whose principal executive
office is located at 1911 Walker Avenue, Monrovia, California 91016, and DAVID
BAILEY (the "Recipient") whose address is 1911 Walker Avenue, Monrovia,
California 91016, pursuant to that certain 1998 STAAR Surgical Company Stock
Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and
approved by the shareholders on May 29, 1998.

      1. GRANT OF OPTION. This Stock Option Certificate certifies that the
Company has granted to the Recipient, pursuant to the terms of the Plan, a stock
option (the "Option") to purchase, in whole or in part, one hundred and fifty
thousand (150,000) shares of the Company's voting common stock, par value $.01
(the "Common Stock") (collectively and severally, the "Option Shares"), at the
price of three dollars and eighty-one cents ($3.81) per Option Share (the
"Option Price"), subject to the following terms and conditions. The date of this
grant January 2, 2002 (the "Grant Date").

      2. PLAN; PLAN SUMMARY. Subject to the terms of this Stock Option
Certificate, the Recipient's rights to purchase the Option Shares are governed
by the Plan, the terms of which are incorporated herein by this reference.
Capitalized terms used in this Stock Option Certificate but not defined herein
shall have the meanings ascribed to them in the Plan.

      3. CHARACTER OF OPTION. This Option (i) is [__] a Non-Qualified Option or
(ii) is [X] an Incentive Option.

      4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the
Recipient's capacity as (i) [X] an employee, (ii) [__] a director, or (iii) [__]
a consultant.

      5. EXPIRATION OF OPTION. The right to exercise the Options granted by this
Stock Option Certificate shall expire and be null and void and of no further
force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the
2nd day of January, 2012 (the "Option Expiration Date"). Nothwithstanding the
foregoing, to the extent the Option is not fully vested, the right to exercise
the Option shall be subject to earlier expiration as provided in Article X of
the Plan.

      6. EXERCISE VESTING CONDITIONS. The Option Shares are subject to Article
V, Section 5.05 of the Plan and to the following vesting schedule:

<TABLE>
<CAPTION>
                           Cumulative Vested
                             Percentage of
     Date                        Shares
---------------            -----------------
<S>                        <C>
January 2, 2003                 33 1/3%
January 2, 2004                 33 1/3%
January 2, 2005                 33 1/3%
</TABLE>

The above vesting schedule will be accelerated according to the Recipient's
achievement of certain goals

<PAGE>

and objectives as stated below:

      (i) the right to purchase thirty thousand (30,000) Option Shares shall
vest immediately upon the Company's receipt of approval from the United States
Food and Drug Administration for use of the Toric ICL as an investigational
device, so long as such approval is received by March 31, 2002;

      (ii) the right to purchase thirty thousand (30,000) Option Shares shall
vest immediately when the Company's product, Visacryl 2, is launched in Germany
and four additional key markets outside the United States, so long as the
product is launched in all five markets by June 30, 2002;

      (iii) the right to purchase thirty thousand (30,000) Option Shares shall
vest on the date that the Company executes an original equipment manufacturer
supply agreement for the Company's existing products yielding revenues in the
first year of not less than $1,500,000, so long as such agreement is signed by
September 30, 2002;

      (iv) the right to purchase thirty thousand (30,000) Option Shares shall
vest immediately once the Company hires a qualified Chief Financial Officer and
qualified Vice President in charge of research and development, clinical affairs
and regulatory affairs, so long as both positions are filled by June 30, 2002;
and

      (v) the right to purchase thirty thousand (30,000) Option Shares shall
vest on April 1, 2002, so long as the Company has achieved and maintained a
positive cash flow during the period from October 1 through December 31, 2001
and January 1 through March 31, 2002.

      7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by
delivery of the Notice of Exercise of Stock Option, in the form attached hereto
as Exhibit A, to the Secretary of the Company, together with:

            (a) A Consent of Spouse (as such consent is defined in the Plan)
      from the spouse of the Recipient, if any, duly signed by such spouse; and

            (b) Full payment for the Option Shares to be purchased in goods
      funds (in U.S. dollars) by cash or check or through a "same day sale"
      commitment from the Recipient and a broker-dealer that is a member of the
      National Association of Securities Dealers (an "NASD Dealer") whereby the
      Recipient irrevocably elects to exercise the Option and to sell a portion
      of the Option Shares so purchased to pay for the Option Price, and whereby
      the NASD Dealer irrevocably commits upon receipt of such Option Shares to
      forward the Option Price directly to the Company.

      8. FORFEITURE; VESTING CONDITIONS. The Option Shares Subject to Article V,
Section 5.05 of the Plan and to the vesting schedule set forth above are subject
to Article X of the Plan and to the forfeiture provisions included therein
relating to the Recipient's continued performance of services in the capacity
indicated above; provided, however, that the vesting schedule and forfeiture
provisions of that certain Employment Agreement entered into by and between the
Recipient and the Company on December 20, 2000.

<PAGE>

      9. VESTING ON CHANGE OF CONTROL. Any unvested Option Shares shall
immediately vest upon the occurrence of a Change In Control or an Approved
Corporate Transaction.

      10. MISCELLANEOUS.

            (a) PREPARATION OF STOCK OPTION CERTIFICATE. This Stock Option
Certificate was prepared by the Company or its legal counsel solely on behalf of
the Company. It is acknowledged by the Recipient that he or she was not
represented by the Company or any of its officers, directors, employees or
agents (including the Company's legal counsel) in connection with the
transaction contemplated by this Stock Option Certificate, and that the
Recipient had separate and independent advice of counsel. In light of the
foregoing it is acknowledged by the Recipient that the Company shall not be
construed to be solely responsible for the drafting hereof, and that any
ambiguity in the Plan or this Stock Option Certificate, or the interpretation
thereof or hereof, shall not be construed against the Company as the alleged
draftsman of this Stock Option Certificate.

            (b) INTERPRETATION.

                  (i) Entire Agreement/No Collateral Representations. The
Recipient acknowledges and agrees that this Stock Option Certificate, together
with and subject to the Plan: (1) is the final, complete and exclusive statement
of the agreement of the parties with respect to the subject matter hereof; (2)
supersedes any prior or contemporaneous agreements or understandings of any
kind, oral or written (collectively and severally, the "prior agreements"), and
that any such prior agreements are of no force or effect except as expressly set
forth herein; and (3) may not be varied, supplemented or contradicted by
evidence of prior agreements, or by evidence of subsequent oral agreements.

                  (ii) Amendment; Waiver. Except as expressly otherwise
provided herein, neither this Stock Option Certificate nor any of its terms may
be amended, supplemented, discharged or terminated (other than by performance),
except as provided in the Plan or by a written instrument or instruments signed
by all of the parties to this Stock Option Certificate. No waiver of any acts or
obligations hereunder shall be effective unless such waiver shall be in a
written instrument or instruments signed by each party claimed to have given or
consented to such waiver and each party affected by such waiver.

                  (iii) Severability. If any term or provision of this Stock
Option Certificate or the application thereof to any person or circumstance
shall, to any extent, be determined to be invalid, illegal or unenforceable
under present or future laws effective during the term of this Stock Option
Certificate, then, and in that event: (A) the performance of the offending term
or provision (but only to the extent its application is invalid, illegal or
unenforceable) shall be excused as if it had never been incorporated into this
Stock Option Certificate, and, in lieu of such excused provision, there shall be
added a provision as similar in terms and amount to such excused provision as
may be possible and be legal, valid and enforceable, and (B) the remaining part
of this Stock Option Certificate (including the application of the offending
term or provision to persons or circumstances other than those as to which it is
held invalid, illegal or unenforceable) shall not be affected thereby and shall
continue in full force and effect to the fullest extent provided by law.

                  (iv) No Reliance Upon Prior Representation. The Recipient
acknowledges that neither the Company nor any of its officers, directors,
employees or agents have made any oral representation or promise which would
induce the Recipient prior to executing this Stock Option Certificate

<PAGE>

to change the Recipient's position to the Recipient's detriment, partially
perform, or part with value in reliance upon such representation or promise; the
Recipient acknowledges that he or she has taken such action at its own risk; and
the Recipient represents that he or she has not so changed his or her position,
performed or parted with value prior to the time of his or her execution of this
Stock Option Certificate.

                  (c) ENFORCEMENT. This Stock Option Certificate and the
rights and remedies of each party arising out of or relating to this Stock
Option Certificate shall be solely governed in accordance with the laws (without
regard to the conflicts of law principles thereof) of the state of Delaware.

                  (d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his
rights or benefits or delegate any of his duties or obligations under this Stock
Option Certificate, in whole or in part, without the prior written consent of
the Company, except pursuant to the terms of the Plan. Subject to the foregoing,
all of the representations, warranties, covenants, conditions and provisions of
this Stock Option Certificate shall be binding upon and shall inure to the
benefit of each party and such party's respective successors and permitted
assigns, spouses, heirs, executors, administrators, and personal and legal
representatives.

                  (e) NOTICES. Unless otherwise specifically provided in this
Stock Option Certificate, all notices, demands, requests, consents, approvals or
other communications (collectively and severally called "notices") required or
permitted to be given hereunder, or which are given with respect to this Stock
Option Certificate, shall be in writing, and shall be given by: (A) personal
delivery (which form of notice shall be deemed to have been given upon
delivery), (B) by telegraph or by private airborne/overnight delivery service
(which forms of notice shall be deemed to have been given upon confirmed
delivery by the delivery agency), (C) by electronic or facsimile or telephonic
transmission, provided the receiving party has a compatible device or confirms
receipt thereof (which forms of notice shall be deemed delivered upon confirmed
transmission or confirmation of receipt), or (D) by mailing in the United States
mail by registered or certified mail, return receipt requested, postage prepaid
(which forms of notice shall be deemed to have been given upon the fifth {5th}
business day following the date mailed).

      WHEREFORE, the parties hereto have for purposes of this Stock Option
Certificate executed this Stock Option Certificate in the City of Monrovia,
County of Los Angeles, State of California, effective as of the 2nd day of
January 2002.

                                         COMPANY:

                                         STAAR Surgical Company,
                                         a Delaware corporation

                                         By: /s/ John Bily
                                             -------------------
                                         John C. Bily, Secretary
ATTEST:

                                         RECIPIENT:

                                             /s/ David Bailey
                                         -----------------------
                                         David Bailey

<PAGE>

                                    EXHIBIT A
                                       TO
                            STOCK OPTION CERTIFICATE

                       NOTICE OF EXERCISE OF STOCK OPTION

<PAGE>

                       NOTICE OF EXERCISE OF STOCK OPTION

          [To be signed by the Recipient only upon exercise of Option]

TO:      Secretary
         STAAR Surgical Company
         1911 Walker Avenue
         Monrovia, California 91016

      The undersigned, the holder of an Option under that certain Stock Option
Certificate dated effective the 2nd day of January , 2002 (the "Option
Certificate"), between STAAR Surgical Company, a Delaware corporation (the
"Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in
accordance with the terms and conditions of that certain 1998 STAAR Surgical
Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17,
1998 and approved by the shareholders on May 29, 1998, under which the Option
Certificate was granted, to exercise the undersigned's Option to purchase
(_______)(1) shares of the Company's voting common stock, $ .01 per share par
value ("Common Stock") (collectively and severally, the "Option Shares"), for
the aggregate purchase price of ($________)(2).

(1)   Insert number of Option Shares as specified in the Option Certificate
      which are vested Option Shares (as defined by the Plan) which the
      Recipient is exercising the Option to purchase.

(2)   Number of Option Shares to be exercised as hereinabove specified
      multiplied by the Option Price per share.

                           Signature:________________________________

                           Print Name:_______________________________

                           Address:__________________________________

                           __________________________________________

                                                      Date:_____________________
